⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 19, 2016Journal of Internal MedicineOpen Access

New ways to subclassify patients with myositis

Ingrid E. Lundberg

View Full Paper

Ask AI

Bookmark

Share

Abstract

Content List – Read more articles from the symposium: The First International Conference on Myositis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ingrid E. Lundberg (2016) studied this question.

synapsesocial.com/papers/69e53c1dbe91d4a9e2d37b9f https://doi.org/10.1111/joim.12515

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Myositis‐specific autoantibodies: an important tool to support diagnosis of myositisReview · 2015 · 1,057 citations
2A New Approach to the Classification of Idiopathic Inflammatory MyopathyPrognostic Study · 1991 · 969 citations
3Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesOriginal Research · 2015 · 50 citations
4Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trialRCT · 2012 · 702 citations
5Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult PolymyositisOriginal Research · 2013 · 281 citations

More related papers

Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis2012
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes2016
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies2001

More from Journal of Internal Medicine

Interacting climatic, environmental, biologic and socio‐economic drivers of the global dengue expansionTue,
Treatment of hyperphagia and obesity in Prader–Willi syndromeThu,